SpineX Inc.
PrivateLast Round
Grant
Sep 26, 2023
Total Funding Raised
$10.47M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
SpineX Inc. is a clinical-stage medical technology company that develops non-invasive spinal cord neuromodulation devices to treat neurological conditions such as neurogenic bladder and cerebral palsy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SpineX Inc. Comparables
Compare SpineX Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PathMaker Neurosystems | 88% | |
| ANEUVO | 88% | |
| ONWARD Medical N.V. | 80% |
SpineX Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 26, 2023 | ||||
| Accelerator | Aug 18, 2023 | ||||
| Seed | Aug 4, 2023 | ||||
| Convertible Debt | Mar 31, 2023 | ||||
| Grant | Feb 28, 2022 |
SpineX Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cerebral Palsy Alliance | Seed |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| The Consortium for Technology & Innovation in Pediatrics | Seed |
| Remarkable | Accelerator |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2026
Grew 83% QoQ, from 6 to 11 employees.
- Jul 20, 2026
Grew 60% QoQ from 5 to 8 employees.
SpineX Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SpineX Inc.'s valuation, stock price, and market status.
Is SpineX Inc. a public or private company?
SpineX Inc. is a private company.
What is the current stock price of SpineX Inc.?
SpineX Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is SpineX Inc. worth (valuation)?
Valuation information for SpineX Inc. is not publicly available.
Can I buy SpineX Inc. stock?
SpineX Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SpineX Inc.'s last funding round?
SpineX Inc.'s most recent funding round was Grant on September 26, 2023.
Who are the main investors in SpineX Inc.?
Key investors in SpineX Inc. include Cerebral Palsy Alliance, National Institute of Diabetes and Digestive and Kidney Diseases, The Consortium for Technology & Innovation in Pediatrics, Remarkable, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Will SpineX Inc. IPO soon?
No public IPO plans have been announced for SpineX Inc..
How can I track SpineX Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SpineX Inc.'s secondary market activity and sign up for updates.